107 related articles for article (PubMed ID: 19488988)
1. HOX D13 expression across 79 tumor tissue types.
Cantile M; Franco R; Tschan A; Baumhoer D; Zlobec I; Schiavo G; Forte I; Bihl M; Liguori G; Botti G; Tornillo L; Karamitopoulou-Diamantis E; Terracciano L; Cillo C
Int J Cancer; 2009 Oct; 125(7):1532-41. PubMed ID: 19488988
[TBL] [Abstract][Full Text] [Related]
2. HOXD13 methylation status is a prognostic indicator in breast cancer.
Zhong Z; Shan M; Wang J; Liu T; Xia B; Niu M; Ren Y; Pang D
Int J Clin Exp Pathol; 2015; 8(9):10716-24. PubMed ID: 26617782
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of HOXD13 expression in human breast cancer.
Zhong ZB; Shan M; Qian C; Liu T; Shi QY; Wang J; Liu Y; Liu Y; Huang YX; Pang D
Int J Clin Exp Pathol; 2015; 8(9):11407-13. PubMed ID: 26617867
[TBL] [Abstract][Full Text] [Related]
4. The HOX gene network in hepatocellular carcinoma.
Cillo C; Schiavo G; Cantile M; Bihl MP; Sorrentino P; Carafa V; D' Armiento M; Roncalli M; Sansano S; Vecchione R; Tornillo L; Mori L; De Libero G; Zucman-Rossi J; Terracciano L
Int J Cancer; 2011 Dec; 129(11):2577-87. PubMed ID: 21626505
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA miR-196a controls melanoma-associated genes by regulating HOX-C8 expression.
Mueller DW; Bosserhoff AK
Int J Cancer; 2011 Sep; 129(5):1064-74. PubMed ID: 21077158
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-10a is overexpressed in human pancreatic cancer and involved in its invasiveness partially via suppression of the HOXA1 gene.
Ohuchida K; Mizumoto K; Lin C; Yamaguchi H; Ohtsuka T; Sato N; Toma H; Nakamura M; Nagai E; Hashizume M; Tanaka M
Ann Surg Oncol; 2012 Jul; 19(7):2394-402. PubMed ID: 22407312
[TBL] [Abstract][Full Text] [Related]
7. The long noncoding RNA HOTAIR has tissue and cell type-dependent effects on HOX gene expression and phenotype of urothelial cancer cells.
Heubach J; Monsior J; Deenen R; Niegisch G; Szarvas T; Niedworok C; Schulz WA; Hoffmann MJ
Mol Cancer; 2015 May; 14():108. PubMed ID: 25994132
[TBL] [Abstract][Full Text] [Related]
8. Analysis of gene expression in cancer cell lines identifies candidate markers for pancreatic tumorigenesis and metastasis.
Missiaglia E; Blaveri E; Terris B; Wang YH; Costello E; Neoptolemos JP; Crnogorac-Jurcevic T; Lemoine NR
Int J Cancer; 2004 Oct; 112(1):100-12. PubMed ID: 15305381
[TBL] [Abstract][Full Text] [Related]
9. Candidate downstream regulated genes of HOX group 13 transcription factors with and without monomeric DNA binding capability.
Williams TM; Williams ME; Kuick R; Misek D; McDonagh K; Hanash S; Innis JW
Dev Biol; 2005 Mar; 279(2):462-80. PubMed ID: 15733672
[TBL] [Abstract][Full Text] [Related]
10. Decreased TIP30 expression predicts poor prognosis in pancreatic cancer patients.
Guo S; Jing W; Hu X; Zhou X; Liu L; Zhu M; Yin F; Chen R; Zhao J; Guo Y
Int J Cancer; 2014 Mar; 134(6):1369-78. PubMed ID: 24037692
[TBL] [Abstract][Full Text] [Related]
11. HOXD13 suppresses prostate cancer metastasis and BMP4-induced epithelial-mesenchymal transition by inhibiting SMAD1.
Xu F; Shangguan X; Pan J; Yue Z; Shen K; Ji Y; Zhang W; Zhu Y; Sha J; Wang Y; Fan L; Dong B; Wang Q; Xue W
Int J Cancer; 2021 Jun; 148(12):3060-3070. PubMed ID: 33521930
[TBL] [Abstract][Full Text] [Related]
12. HOXD13 promotes the malignant progression of colon cancer by upregulating PTPRN2.
Yin J; Guo Y
Cancer Med; 2021 Aug; 10(16):5524-5533. PubMed ID: 34272834
[TBL] [Abstract][Full Text] [Related]
13. Hoxd13 binds in vivo and regulates the expression of genes acting in key pathways for early limb and skeletal patterning.
Salsi V; Vigano MA; Cocchiarella F; Mantovani R; Zappavigna V
Dev Biol; 2008 May; 317(2):497-507. PubMed ID: 18407260
[TBL] [Abstract][Full Text] [Related]
14. Expression of HOXB2, a retinoic acid signaling target in pancreatic cancer and pancreatic intraepithelial neoplasia.
Segara D; Biankin AV; Kench JG; Langusch CC; Dawson AC; Skalicky DA; Gotley DC; Coleman MJ; Sutherland RL; Henshall SM
Clin Cancer Res; 2005 May; 11(9):3587-96. PubMed ID: 15867264
[TBL] [Abstract][Full Text] [Related]
15. HOX genes and their role in the development of human cancers.
Bhatlekar S; Fields JZ; Boman BM
J Mol Med (Berl); 2014 Aug; 92(8):811-23. PubMed ID: 24996520
[TBL] [Abstract][Full Text] [Related]
16. Identification of pancreatic cancer-specific cell-surface markers for development of targeting ligands.
Morse DL; Hostetter G; Balagurunathan Y; Gillies RJ; Han H
Methods Mol Biol; 2010; 624():195-210. PubMed ID: 20217597
[TBL] [Abstract][Full Text] [Related]
17. In vitro modeling of human pancreatic duct epithelial cell transformation defines gene expression changes induced by K-ras oncogenic activation in pancreatic carcinogenesis.
Qian J; Niu J; Li M; Chiao PJ; Tsao MS
Cancer Res; 2005 Jun; 65(12):5045-53. PubMed ID: 15958547
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of cancer cell proliferation by designed peptide amphiphiles.
Aulisa L; Forraz N; McGuckin C; Hartgerink JD
Acta Biomater; 2009 Mar; 5(3):842-53. PubMed ID: 19249722
[TBL] [Abstract][Full Text] [Related]
19. cAMP induced modifications of HOX D gene expression in prostate cells allow the identification of a chromosomal area involved in vivo with neuroendocrine differentiation of human advanced prostate cancers.
Cantile M; Kisslinger A; Cindolo L; Schiavo G; D'Antò V; Franco R; Altieri V; Gallo A; Villacci A; Tramontano D; Cillo C
J Cell Physiol; 2005 Nov; 205(2):202-10. PubMed ID: 15895411
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of SIX1 is an independent prognostic marker in stage I-III colorectal cancer.
Kahlert C; Lerbs T; Pecqueux M; Herpel E; Hoffmeister M; Jansen L; Brenner H; Chang-Claude J; Bläker H; Kloor M; Roth W; Pilarsky C; Rahbari NN; Schölch S; Bork U; Reissfelder C; Weitz J; Aust D; Koch M
Int J Cancer; 2015 Nov; 137(9):2104-13. PubMed ID: 25951369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
